Evidence map›Paper›PMID 39451757›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Factors Influencing the Timeliness and Completeness of Appropriate Staging Investigations for Patients with Stage I-III Lung Cancer in Southeastern Ontario.

Shahad AlGhamdi, Nilah Ahimsadasan, Weidong Kong, Michael Brundage, Elizabeth A Eisenhauer, Christopher M Parker, Andrew Robinson, Andrew Giles, Geneviève C Digby

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shahad AlGhamdiDepartment of Medicine, Division of Respirology, Queen's University, Kingston, ON K7L 2V7, Canada.ORCID 0009-0001-9881-8665
Nilah AhimsadasanSchool of Medicine, Queen's University, Kingston, ON K7L 2V7, Canada.
Weidong KongCancer Care and Epidemiology Research Unit, Queen's University, Kingston, ON K7L 2V7, Canada.
Michael BrundageDepartment of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.
Elizabeth A EisenhauerDepartment of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.
Christopher M ParkerDepartment of Medicine, Division of Respirology, Queen's University, Kingston, ON K7L 2V7, Canada.
Andrew RobinsonDepartment of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.
Andrew GilesDepartment of Surgery, Division of Thoracic surgery, Queen's University, Kingston, ON K7L 2V7, Canada.ORCID 0000-0002-9956-0694
Geneviève C DigbyDepartment of Medicine, Division of Respirology, Queen's University, Kingston, ON K7L 2V7, Canada.ORCID 0000-0002-1858-0387

Funding

Division of Respirology UHKF Research Award N.A.Ontario Lung Association Young Investigator AwardTranslational Institute of Medicine at Queen's University N.A.
6 · The paper itself

Abstract

(1) Background: Comprehensive and timely lung cancer (LC) staging is essential for prognosis and management. The Lung Diagnostic Assessment Program (LDAP) in Southeastern (SE) Ontario aims to provide rapid, guideline-concordant care for suspected LC patients. We evaluated factors affecting the completeness and timeliness of staging for stage I-III LC patients in SE Ontario, including the impact of LDAP management. (2) Methods: This was a population-based retrospective cohort study using the LDAP database (January 2017-December 2019), linked with the Ontario Cancer Registry, to identify newly diagnosed LC patients. A Cox model approach identified variables associated with staging completeness and timeliness. (3) Results: Among 755 patients, 459 (60.8%) were managed through LDAP. Optimal staging was achieved in 596 patients (78.9%), 23 (3.0%) had alternative staging, and 136 (18.0%) had incomplete staging. In the adjusted analyses, LDAP management was associated with a higher likelihood of complete staging (OR 2.29,

Indexed as

Lung NeoplasmsNeoplasm StagingAgedAged, 80 and overFemaleHumansMaleMiddle AgedOntarioRetrospective StudiesTime Factorslung cancermultidisciplinary clinicstagingsystem barriers

Identifiers

PMID39451757
PMCPMC11505813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.